首页> 外文期刊>Laboratory investigation >Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines
【24h】

Alterations of DNA mismatch repair proteins and microsatellite instability levels in gastric cancer cell lines

机译:胃癌细胞系DNA错配修复蛋白和微卫星不稳定性水平的变化

获取原文
           

摘要

Alterations in DNA mismatch repair (MMR) proteins result in microsatellite instability (MSI), increased mutation accumulation at target genes and cancer development. About one-third of gastric cancers display high-level microsatellite instability (MSI-High) and low-level microsatellite instability (MSI-Low) is frequently detected. To determine whether variations in the levels of MMR proteins or mutations in the main DNA MMR genes are associated with MSI-Low and MSI-High in gastric cancer cell lines, the MSI status (MSI-High, MSI-Low or MS-Stable (MSS)) of 14 gastric cancer lines was determined using multiple clone analysis with a panel of five microsatellite markers. Protein levels of hMLH1, hMSH2, hMSH6, hPMS2 and hPMS1 were determined by Western blot. Sequence analysis of hMLH1 and hMSH2 was performed and the methylation status of the hMLH1 promoter was examined. The cell lines SNU1 and SNU638 showed MSI-High, decreased to essentially absent hMLH1 and hPMS2 and reduced hPMS1 and hMSH6 protein levels. The hMLH1 promoter region was hypermethylated in SNU638 cells. The MKN28, MKN87, KATOIII and SNU601 cell lines showed MSI-Low. The MMR protein levels of cells with MSI-Low status was similar to the levels detected in MSS cells. A marked decrease in the expression levels of MutL MMR proteins (hMLH1, hPMS2 and hPMS1) is associated with high levels of MSI mutations in gastric cancer cells. Gastric cancer cell lines with MSI-Low status do not show significant changes in the levels of the main DNA MMR proteins or mutations in the DNA mismatch repair genes hMSH2 and hMLH1. These well-characterized gastric cancer cell lines are a valuable resource to further our understanding of DNA MMR deficiency in cancer development, progression and prognosis.
机译:DNA错配修复(MMR)蛋白的变化导致微卫星不稳定性(MSI),靶基因上突变积累的增加和癌症的发展。大约三分之一的胃癌表现出高水平的微卫星不稳定性(MSI-高),经常检测到低水平的微卫星不稳定性(MSI-Low)。为了确定MMR蛋白水平的变化或主要DNA MMR基因的突变是否与胃癌细胞系中的MSI-Low和MSI-High相关,MSI的状态(MSI-High,MSI-Low或MS-Stable(使用一组五个微卫星标记的多重克隆分析确定了14个胃癌细胞系的MSS)。通过蛋白质印迹法测定hMLH1,hMSH2,hMSH6,hPMS2和hPMS1的蛋白水平。进行了hMLH1和hMSH2的序列分析,并检查了hMLH1启动子的甲基化状态。 SNU1和SNU638细胞系显示MSI-高,降至基本不存在hMLH1和hPMS2,并且降低了hPMS1和hMSH6蛋白水平。 hMLH1启动子区域在SNU638细胞中被高度甲基化。 MKN28,MKN87,KATOIII和SNU601细胞系显示MSI低。 MSI-Low状态的细胞的MMR蛋白水平与MSS细胞中检测到的水平相似。 MutL MMR蛋白(hMLH1,hPMS2和hPMS1)的表达水平显着下降与胃癌细胞中高水平的MSI突变有关。 MSI-Low状态的胃癌细胞系未显示主要DNA MMR蛋白水平的显着变化或DNA错配修复基因hMSH2和hMLH1的突变。这些特征明确的胃癌细胞系是进一步了解DNA MMR在癌症发展,进展和预后中缺乏的宝贵资源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号